PR.com is a leader in paid and free press release distribution.
To reach journalists, increase online visibility, and attract new customers,
submit via our global online news and press release distribution service to
top search engines, thousands of websites, social media, blogger networks,
as well as via print, broadcast, radio, mobile channels, and more.
Pediatric Cancer Research Foundation to host its annual fundraiser to benefit pediatric cancer research. - March 15, 2019 - Pediatric Cancer Research Foundation
A portion of sales from an exclusive March 14th evening event will benefit Pediatric Cancer Research Foundation (PCRF), funding research to improve the care, quality of life, and survival rate of children battling cancer. - March 15, 2019 - Pediatric Cancer Research Foundation
At just 2-1/4 inches in height, while isolating vibrations as low as 1 hertz, the new completely-passive Negative-Stiffness tabletop vibration isolation platform – developed by Minus K Technology – provides the industry’s thinnest low-height, low-frequency isolator for optimizing space in critical microscopy and laboratory applications. - March 14, 2019 - Minus K Technology Inc.
Significantly increased revenue from sales and performance compared with the past two years (+ 14.6% compared with 2017 and + 30% compared with 2016) for the company which focuses on laser therapy for both the Human and Veterinary sectors. The forecast target for 2019: a further increase in revenue from budgeted sales of 5.5% compared with the 2018 result. - March 14, 2019 - ASA srl
Scintica Instrumentation Inc. is excited to announce its recent distribution agreement for the Baker Ruskinn preclinical VelO2x hypoxia chamber for scientific research. The VelO2x system has been engineered to provide an isolated and highly controlled oxygen environment to help researchers better understand how O2 levels affect various conditions such as sleep apnea, systemic hypertension, pulmonary dysfunction, ischemia and much more. - March 07, 2019 - Scintica Instrumentation
Apostle Inc is pleased to announce an exclusive partnership with Beckman Coulter, a world leader in Life Sciences, for Apostle MiniMaxTMHigh Efficiency Cell-Free DNA Isolation Kit. As cell-free DNA (cfDNA) workflows move beyond theoretical and into human health applications, Apostle's industry leading... - February 28, 2019 - Apostle Inc
The Cardiac and Vascular Institute was certified as a great workplace by the independent analysts at Great Place to Work®. TCAVI earned this credential based on direct feedback from employees, provided as part of an extensive and anonymous survey about the workplace experience. A summary of these... - February 26, 2019 - The Cardiac & Vascular Institute
Reproductive Medicine Associates of New York (RMA of New York), a global leader in state-of-the-art reproductive medicine, is pleased to announce the promotion of Georgia Witkin, Ph.D. to Director of Psychological and Wellness Services.
Dr. Witkin has been practicing at RMA of New York since its inception... - February 20, 2019 - Reproductive Medicine Associates of New York
A 3D ultrasound imaging system for mice, rats and other small animals is now available to scientists throughout North America and Europe. The Prospect T1 is a cost effective, tablet based, high-frequency ultrasound imaging system, optimized to study hemodynamics and vascular function at the laboratory benchtop instead of from inside a core imaging facility. Scintica Instrumentation has the exclusive rights to sell and service the Prospect T1 with its team of scientific experts. - February 14, 2019 - Scintica Instrumentation Inc.
ALPCO awards its January 2019 Diabetes Research Travel Grant to Lisa Volpatti at Massachusetts Institute of Technology. - February 05, 2019 - ALPCO
Mr. Gregory is recognized as a proven executive leader with big company capabilities and a keen start-up mindset, and his achievements include executing a successful IPO, driving substantial revenue & earning multiples for a publicly traded company, marshalling medical technologies through positive M&A efforts, and generating $50M+ in corporate financing efforts. - February 04, 2019 - Perthera, Inc.
Red Pill Medical's CEO Gregory A. Smith, M.D. (Producer of the American Addict films) has rolled out a new science-based line of CBD products designed for everyday use to address a variety of common complaints to help people reach their personal peak. - January 31, 2019 - Red Pill Medical, Inc.
Paras Biopharmaceuticals Finland Oy today announced the achievement of a major milestone – the successful development of biologically active Romiplostim (N-Plate® biosimilar) production technology.
Romiplostim has been produced with a proprietary and innovative continuous manufacturing process... - January 31, 2019 - Paras Biopharmaceuticals Finland Oy
After 15 year of research in collaboration with renowned Oncologists and Scientists, LifeBiotic is launching Protectival, a natural product boosting immunity and cellular health. - January 26, 2019 - Lifebiotic
The Pediatric Cancer Research Foundation announces the addition of two new Board of Directors in 2019. - January 26, 2019 - Pediatric Cancer Research Foundation
The Pediatric Cancer Research Foundation announces its new 2019 grantees in the fight against pediatric cancer. - January 17, 2019 - Pediatric Cancer Research Foundation
The common mosquito, while being responsible for up to a million human deaths each year, may paradoxically also hold biochemical secrets to cure diseases that effect hundreds of millions of people around the globe. - January 12, 2019 - Bioquark Inc.
ReproTech, Ltd.’s three facilities, in Minnesota, Florida and Nevada, have again been awarded the prestigious accreditation of the American Association of Tissue Banks (AATB), as well as its Texas facility receiving first-time AATB accreditation, it was announced in December, 2018 by Brent Hazelrigg,... - January 11, 2019 - ReproTech, Ltd.
The Cardiac & Vascular Institute (TCAVI) and North Florida Regional Medical Center (NFRMC) collaborated this week to test an artificial intelligence (AI) device designed to alert clinicians to bleeding episodes during endovascular procedures.
According to a press release, the AI device, (named Early... - January 09, 2019 - The Cardiac & Vascular Institute
Scintica Instrumentation Inc. is excited to announce their distribution agreement in North America and Europe for Aspect Imaging’s preclinical M-Series™ Compact MRI system. The M-Series™ enable high-resolution 3D imaging without the need for special shielding, cryogens or water connections. Gold standard and affordable MR imaging can now be integrated into individual scientific laboratories, allowing researchers to harness the power and insights of MRI quickly and easily. - January 09, 2019 - Scintica Instrumentation Inc.
Knowing how mutations in cancer cells work will help researchers better understand how they evolve to become resistant to drugs. - December 14, 2018 - Genome Institute of Singapore
A team of scientists from Agency for Science, Technology and Research’s (A*STAR) Genome Institute of Singapore (GIS) has identified a new approach to cancer therapeutics by targeting the evolution of cancer cells. This approach prevents or delays the progression of cancer into treatmentresistant/metastatic... - December 12, 2018 - Genome Institute of Singapore
GeneFluidics is the only group selected for both NIAID antimicrobial resistance diagnostics projects (https://www.nih.gov/news-events/news-releases/nih-funds-nine-antimicrobial-resistance-diagnostics-projects) and as finalists for the NIH AMR Challenge Step 2 (https://dpcpsi.nih.gov/AMRChallenge/Finalists). - December 05, 2018 - GeneFluidics Inc.
Venture capital firm announces transaction in online digital platform, investment to lead to strategic growth in the integrative medical space. - November 23, 2018 - International Peptide Society
The company from Vicenza, (Italy), a leader in the production of laser therapy, launches a new high-performing device at “Medica 2018” which offers early and scientifically proven results by combining the synchronised action of MLS® Laser Therapy with the pulse power of Hilterapia®. - November 20, 2018 - ASA srl
Wheeling Hospital has become the first U.S. medical facility to use the Matrix IT’s TRACTUS Scanner system to enhance the tracking of surgical implantable devices.
Wheeling Hospital was selected to conduct trials of Matrix IT’s TRACTUS Scanner system.
The surgical implantable devices either... - November 15, 2018 - Matrix Medical Tracking Systems
ReproTech, Ltd., a cryobank specializing in long-term storage of human reproductive tissue (sperm, eggs, embryos and ovarian/testicular tissue), was proud to sponsor local staff in multiple 2018 cancer research fundraisers. - November 09, 2018 - ReproTech, Ltd.
North County Health Services Reveals Recent Remodel. - November 01, 2018 - NCHS
Corporate Compliance and Ethics Week, November 4-10, 2018 - November 01, 2018 - ProPath
ALPCO announces launch of its new highly specific FDA Class I Exempt STELLUX® Chemi Glucagon ELISA. - October 23, 2018 - ALPCO
Credo Biomedical is one of the 12 finalists that have been selected to showcase during the Animal Health Innovation Summit in Hong Kong. - October 21, 2018 - Credo Biomedical Pte. Ltd.
Epitope Diagnostics, Inc. (EDI), is pleased to announce it has received certification for the Vitamin D Standardization Program (VDSP) for vitamin D measurement in the EDI™ Total 25-OH Vitamin D EIA Kit. CDC’s Vitamin D Standardization-Certification Program (VDSCP) evaluates the accuracy... - October 21, 2018 - Epitope Diagnostics, Inc.
A new finish line accomplished for ASAlaser, whose scientific magazine celebrates its first ten years in 2018. The magazine represents just one of the company’s initiatives for highlighting research, the focal point of its growth and the basis of its ethics. - October 19, 2018 - ASA srl
ALPCO announces the first recipient of its new young investigators award, the Diabetes Research Travel Grant. - October 17, 2018 - ALPCO
We often take for granted the ability to smell, but people with a diminished sense of smell or who have lost this sense completely know that this ability is linked to our overall quality of life. It is a major contributor to our ability to taste food, and people who lose their sense of smell often lose their appetite. This clinical trial may give them hope. - October 15, 2018 - Foundation for Regenerative Medicine
ALPCO announces that its quality management system recently received the distinguished ISO 13485:2016 certification from Intertek to ensure the quality, safety and efficacy of its products in the clinical diagnostics field. - October 09, 2018 - ALPCO
ProPath is pleased to announce that they have been selected as the pathology service provider for Baylor Scott & White Medical Center – Sunnyvale. In addition, ProPath’s Dr. Isabel Hill has been named Medical Director of Pathology Services.
“ProPath is excited to provide the pathology... - October 04, 2018 - ProPath
The Olympics, the World Championships and international competitions distinguished by victories have marked the ten years of collaboration between the Italian company ASAlaser from Vicenza, manufacturer of lasers for rehabilitation and physiotherapy, and the Azzurri Italian fencing team. These were also underlined by the recent successes at Wuxi 2018. - September 27, 2018 - ASA srl
Epitope Diagnostics, Inc. is pleased to announce it has been selected to take part in MetroConnect 2018, an export assistance program run by the World Trade Center San Diego (WTC) and designed to help San Diego companies accelerate their global growth.
This program will allow Epitope Diagnostics to... - September 23, 2018 - Epitope Diagnostics, Inc.
The addition of the two new urologists/robotic surgeons will bring The Urology Center of Colorado (TUCC) to a total of 18 physicians and 4 advanced practice providers to remain the largest urology group in Colorado. All TUCC physicians are sub-specialists committed to providing excellence at every encounter. - September 21, 2018 - The Urology Center of Colorado
Program greatly extends access to fertility preservation services. - September 20, 2018 - ReproTech, Ltd.
VirtuOx, one of the world’s largest home diagnostic testing providers, and Brightree®, the leading provider of cloud-based healthcare software and solutions for the post-acute market, have announced a completed integration that enables streamlined workflows for home medical equipment companies... - September 17, 2018 - VirtuOx
Recovery Unplugged Treatment Centers kicked-off a multimedia marketing campaign in observance of National Recovery Month. The campaign aims to promote awareness, education, and empowerment throughout the recovery community and their loved ones. Content is being created that celebrate those in recovery, provide information to help people stay clean, and educate loved ones about treatment and the recovery process. - September 08, 2018 - Recovery Unplugged
Recovery Unplugged Treatment Centers is being featured in USA Today's Addiction and Mental Health Awareness issue on Thursday, September 13th. The "Three Stories" multimedia campaign created by Recovery Unplugged highlights the stories of three mothers and their children who have made it to the other side of addiction - together. - September 08, 2018 - Recovery Unplugged
The XXXIII Biennial Meeting of the International Society of Eye Research takes place this year from September 9-13th in Belfast, Northern Ireland, UK. Dr Jenni J. Hakkarainen – Acting COO of Experimentica Ltd. will present an oral presentation on a metalloporphyrin superoxide dismutase mimetic and the dry-eye disease. Dr Simon Kaja – CSO of Experimentica Ltd. will chair a session and present on cellular mechanisms of reactive astrocytosis and opportunities for glioprotection. - September 08, 2018 - Experimentica Ltd
Trial Runners is pleased to announce additions to their executive team as well as their leadership team as a result of a fast-paced growth year. - August 17, 2018 - Trial Runners
CTi (Clinical Trials Intelligence) aims to bring down the cost of medicine, as well as increase the speed of access to new medicine, by reducing development costs for the global pharmaceutical industry. - August 08, 2018 - ClinTex Ltd
ALPCO will promote the expansion of its STELLUX® Chemiluminescence ELISA platform, as well as its current therapeutic drug monitoring portfolio, gastroenterology testing panel, and assay qualification program at AACC’s 70th Annual Clinical Lab Expo. - July 25, 2018 - ALPCO
ALPCO and InSphero announce partnership to provide customers with a complete solution to assess beta-cell function in islet microtissue culture models. - July 24, 2018 - ALPCO
The ASAlaser therapeutic solutions are an effective answer in order to successfully treat one of the most common issues for freestyle and backstroke lovers. Hilterapia® and MLS® provide a fast reduction in pain and a speedy recovery of the joint’s action. - July 22, 2018 - ASA srl